Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiglitazar + Metformin in Type 2 Diabetes
NCT00762957Phase 3Terminated
- Sponsor
- Takeda
- Start
- Nov 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of imiglitazar in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Nov 2004; status: terminated.
02
Drugs
imiglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00762957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762957.